What is Clarapath?
Founded in 2014 and headquartered in Hawthorne, New York, Clarapath is at the forefront of medical robotics, aiming to catalyze transformative change in pathology laboratory operations. The company's innovative solutions are designed to enhance efficiency, accuracy, and throughput in diagnostic processes, addressing critical needs within the healthcare industry. By leveraging advanced robotics and automation, Clarapath seeks to improve the speed and reliability of pathological analysis, ultimately contributing to better patient outcomes. The company's focus on this specialized segment of medical technology positions it as a key player in the evolving landscape of diagnostic services.
How much funding has Clarapath raised?
Clarapath has raised a total of $68M across 2 funding rounds:
Series B
$32M
Series B
$36M
Series B (2021): $32M with participation from Epiphron Capital Group, East Post Road Ventures, and P5 Health Ventures
Series B (2024): $36M led by Mayo Clinic and CU Healthcare Innovation Fund
Key Investors in Clarapath
Epiphron Capital Group
Epiphron Capital Group is an investor participating in the funding round. Further details on their specific investment focus are not provided.
East Post Road Ventures
East Post Road Ventures is an investor participating in the funding round, likely focusing on early-stage healthcare innovations and medical devices.
P5 Health Ventures
P5 Health Ventures is an investor participating in the funding round, with a known interest in companies that enhance healthcare and promote healthier living through diagnostics and AI.
What's next for Clarapath?
The recent major strategic investment signifies a strong vote of confidence in Clarapath's technology and market potential. This capital infusion is anticipated to fuel further research and development, enabling the company to enhance its existing product offerings and potentially explore new applications for its robotics platform. Expansion of manufacturing capabilities and sales infrastructure is also likely, as Clarapath aims to scale its operations to meet growing demand. Strategic partnerships and collaborations within the healthcare ecosystem may also be pursued to broaden its impact and solidify its position as a leader in medical robotics for pathology.
See full Clarapath company page
